Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Peripheral T-Cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07639879
What this trial is testing

TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
PTCLNK T-Cell Lymphoma
Tarapeutics Science Inc. 180
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT05140382
What this trial is testing

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

Who this might be right for
Relapsed/Refractory Peripheral T-cell LymphomaRelapsed/Refractory Classical Hodgkins Lymphoma
AstraZeneca 52
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT01606878
What this trial is testing

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Who this might be right for
Childhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma
Children's Oncology Group 46
Testing effectiveness (Phase 2)UnknownNCT06492629
What this trial is testing

Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
PTCL
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)Study completedNCT00005080
What this trial is testing

506U78 in Treating Patients With Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma+11 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Not Yet RecruitingNCT06385522
What this trial is testing

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Who this might be right for
NHLCutaneous T Cell LymphomaPeripheral T-cell Lymphoma
Boston Immune Technologies and Therapeutics 37
Testing effectiveness (Phase 2)Looking for participantsNCT06810778
What this trial is testing

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center 12
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Looking for participantsNCT07523555
What this trial is testing

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more
Beijing Biotech 96
Testing effectiveness (Phase 2)Ended earlyNCT00972842
What this trial is testing

Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Non-Hodgkin's Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 20
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page